Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Short-Course Zuranolone Looks Promising for MDD

Posted by SLS on July 5, 2021, at 11:19:02

In reply to Re: Short-Course Zuranolone Looks Promising for MDD, posted by TriedEveryMedication on July 2, 2021, at 10:07:34

> "A potential limitation of brexanolone is the estimated cost of $34,000 for one continuous infusion,"

Brexanolone (Zulresso) is approved as an I.V. drug, and is approved for postpartum depression only.

Zurazolone is to be taken orally. This is the drug that I had been waiting for a few years. Sage Therapeutic (and Biogen) have conducted a Phase III clinical trial that reports a favorable therapeutic effect. It looks like zuranolone might be approved for postpartum depression, major depressive disorder, and bipolar depression.

- Scott

Some see things as they are and ask why.
I dream of things that never were and ask why not.

The only thing necessary for the triumph of evil is that good men do nothing.




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:1115627